– Strategic Expansion into Southern European Market Through Partnership with Exclusive Distributor –
ThinkCyte, a biotechnology company developing AI-driven cell analysis and sorting technology, is pleased to announce the successful delivery and completion of the first-ever placement of its VisionSort™ system in Italy. The system was installed at Cytosens, ThinkCyte’s exclusive distributor in Italy, marking a significant milestone in the company’s global expansion.
The newly installed VisionSort™ system will serve as a dedicated demonstration unit for the Southern European region, covering Italy, Spain, and Portugal. This placement enables ThinkCyte and Cytosens to offer local researchers and biopharmaceutical companies hands-on access to next-generation cell sorting technology, thereby strengthening the partnership between the two companies.
About ThinkCyte
ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development. The company’s flagship product, VisionSort, is the world’s first AI-based, dual-mode fluorescence and morphometric cell sorting platform and it partners with major global biopharmaceutical companies and leading academic research institutes to further drive groundbreaking research. For more information, please visit www.thinkcyte.com.
To learn more about research partnerships or other partnering opportunities with ThinkCyte, email contact@thinkcyte.com.
